Validation of the Myelofibrosis Secondary to PV and ET-Prognostic Model in Newly Diagnosed Patients with Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis: MD Anderson Cancer Center

被引：0
|
作者：
Masarova, Lucia [1 ]
Kantarjian, Hagop [1 ]
Verstovsek, Srdan [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-031
引用
收藏
页码：S20 / S21
页数：2
相关论文
共 50 条
  • [21] Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project
    Mora, Barbara
    Giorgino, Toni
    Guglielmelli, Paola
    Rumi, Elisa
    Maffioli, Margherita
    Rambaldi, Alessandro
    Caramella, Marianna
    Komrokji, Rami
    Gotlib, Jason
    Kiladjian, Jean Jacques
    Cervantes, Francisco
    Devos, Timothy
    Palandri, Francesca
    De Stefano, Valerio
    Ruggeri, Marco
    Silver, Richard T.
    Benevolo, Giulia
    Albano, Francesco
    Cavalloni, Chiara
    Barraco, Daniela
    Merli, Michele
    Pietra, Daniela
    Casalone, Rosario
    Barbui, Tiziano
    Rotunno, Giada
    Cazzola, Mario
    Vannucchi, Alessandro Maria
    Passamonti, Francesco
    HAEMATOLOGICA, 2018, 103 (09) : E392 - E394
  • [22] A phase II trial of oral panobinostat (LBH589), a no deacetylase inhibitor (DACi) in patients with primary myelofibrosis (PMF), post-essential thrombocythemia (ET) myelofibrosis, and post-polycythemia vera (PV) myelofibrosis
    DeAngelo, D. J.
    Tefferi, A.
    Mesa, R. A.
    Paley, C. S.
    Wadleigh, M.
    Snyder, D.
    Ondovik, M. S.
    Rine, J.
    Bhalla, K. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
    Mascarenhas, John
    Sandy, Lonette
    Lu, Min
    Yoon, James
    Petersen, Bruce
    Zhang, David
    Ye, Fei
    Newsom, Carrie
    Najfeld, Vesna
    Hochman, Tsivia
    Goldberg, Judith D.
    Hoffman, Ronald
    LEUKEMIA RESEARCH, 2017, 53 : 13 - 19
  • [24] A Novel Prognostic Model Including Cytogenetic and Molecular Data in Patients with Primary and Post-Essential Thrombocythemia (ET)/Polycythemia Vera (PV) Myelofibrosis (MF)
    Santos, Fabio P. S.
    Getta, Bartlomiej
    Masarova, Lucia
    Famulare, Christopher
    Schulman, Jessica
    Datoguia, Tarcila Santos
    Goncalves, Giulliana A. R.
    Hamerschlak, Nelson
    Kantarjian, Hagop M.
    Levine, Ross L.
    Campregher, Paulo Vidal
    Rampal, Raajit K.
    Verstovsek, Srdan
    BLOOD, 2018, 132
  • [25] A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
    Mascarenhas, J.
    Marcellino, B. K.
    Lu, M.
    Kremyanskaya, M.
    Fabris, F.
    Sandy, L.
    Mehrotra, M.
    Houldsworth, J.
    Najfeld, V.
    El Jamal, S.
    Petersen, B.
    Moshier, E.
    Hoffman, R.
    LEUKEMIA RESEARCH, 2020, 88
  • [26] CYTOGENETIC ABNORMALITIES IN POST-POLYCYTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: CORRELATIONS WITH GENOTYPE AND PHENOTYPE IN THE MYSEC STUDY
    Mora, B.
    Giorgino, T.
    Guglielmelli, P.
    Rumi, E.
    Maffioli, M.
    Rambaldi, A.
    Caramella, M.
    Komrokji, R.
    Gotlib, J.
    Kiladjian, J. J.
    Cervantes, F.
    Devos, T.
    Palandri, F.
    De Stefano, V.
    Ruggeri, M.
    Silver, R. T.
    Benevolo, G.
    Albano, F.
    Caramazza, D.
    Merli, M.
    Pietra, D.
    Casalone, R.
    Barbui, T.
    Rotunno, G.
    Cazzola, M.
    Vannucchi, A. M.
    Passamonti, F.
    HAEMATOLOGICA, 2017, 102 : 3 - 4
  • [27] CYTOGENETIC ABNORMALITIES IN POST-POLYCYTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: CORRELATIONS WITH GENOTYPE AND PHENOTYPE IN THE MYSEC STUDY
    Mora, B.
    Giorgino, T.
    Guglielmelli, P.
    Rumi, E.
    Maffioli, M.
    Caramazza, D.
    Rambaldi, A.
    Caramella, M.
    Komrokji, R.
    Gotlib, J.
    Kiladjian, J. J.
    Cervantes, F.
    Devos, T.
    Palandri, F.
    De Stefano, V.
    Ruggeri, M.
    Silver, R. T.
    Benevolo, G.
    Albano, F.
    Merli, M.
    Pietra, D.
    Casalone, R.
    Barbui, T.
    Rotunno, G.
    Cazzola, M.
    Vannucchi, A. M.
    Passamonti, F.
    HAEMATOLOGICA, 2017, 102 : 117 - 118
  • [28] The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis
    Hernandez-Boluda, Juan-Carlos
    Pereira, Arturo
    Gomez, Montse
    Boque, Concepcion
    Ferrer-Marin, Francisca
    Raya, Jose-Maria
    Garcia-Gutierrez, Valentin
    Kerguelen, Ana
    Xicoy, Blanca
    Barba, Pere
    Martinez, Jesus
    Luno, Elisa
    Alvarez-Larran, Alberto
    Martinez-Lopez, Joaquin
    Arbelo, Elisa
    Besses, Carles
    HAEMATOLOGICA, 2014, 99 (04) : E55 - E57
  • [29] Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project
    Daniela Barraco
    Barbara Mora
    Paola Guglielmelli
    Elisa Rumi
    Margherita Maffioli
    Alessandro Rambaldi
    Marianna Caramella
    Rami Komrokji
    Jason Gotlib
    Jean Jacques Kiladjian
    Francisco Cervantes
    Timothy Devos
    Francesca Palandri
    Valerio De Stefano
    Marco Ruggeri
    Richard T. Silver
    Giulia Benevolo
    Francesco Albano
    Michele Merli
    Daniela Pietra
    Tiziano Barbui
    Giada Rotunno
    Mario Cazzola
    Toni Giorgino
    Alessandro Maria Vannucchi
    Francesco Passamonti
    Blood Cancer Journal, 8
  • [30] Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group
    Mora, Barbara
    Guglielmelli, Paola
    Rumi, Elisa
    Maffioli, Margherita
    Barraco, Daniela
    Rambaldi, Alessandro
    Caramella, Marianna
    Komrokji, Rami S.
    Kiladjian, Jean-Jacques
    Gotlib, Jason
    Iurlo, Alessandra
    Cervantes, Francisco
    Devos, Timothy
    Palandri, Francesca
    De Stefano, Valerio
    Ruggeri, Marco
    Silver, Richard T.
    Albano, Francesco
    Benevolo, Giulia
    Cavalloni, Chiara
    Uccella, Silvia
    Accetta, Raffaella
    Siracusa, Claudia
    Agnoli, Stefania
    Merli, Michele
    Barbui, Tiziano
    Bertu, Lorenza
    Cazzola, Mario
    Vannucchi, Alessandro M.
    Passamonti, Francesco
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (01) : E1 - E3
12345